Information and Communication Technology (ICT)- Based Centralized Monitoring System of Asthma Control

NCT03327363 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-10-31

No results posted yet for this study

Summary

The aims of this study is to evaluation of the clinical efficacy and stability of Information and Communication Technology (ICT)- based centralized monitoring system of asthma control monitoring in asthma patients. We planed to enroll 100 asthma patients (50 subjects using ICT systems, 50 controls). We will monitor the asthma control status, lung function, exacerbation rate and stability of ICT systems.

This study is based upon work supported by the Ministry of Trade, Industry \& Energy (MOTIE, Korea) under industrial Technology Innovation Program (No. 10059066, 'Establishment of ICT Clinical Trial System and Foundation for Industrialization').

Conditions

Interventions

DEVICE

Feedback using ICT based monitoring system

In experimental group, the subjects the check their lung function using self FEV1 monitoring device (microlife PF-200). They send the information to central monitoring system(EDC systems). In case of decreased FEV1 compared with own average FEV1, the ICT based monitoring system send the feedback message to the subject and medical staffs.

Sponsors & Collaborators

  • Ministry of Trade, Industry & Energy, Republic of Korea

    collaborator OTHER_GOV
  • Korea Evaluation Institute of Industrial Technology

    collaborator OTHER
  • Daegu Metropolitan City, Korea

    collaborator OTHER_GOV
  • ICT Clinical Trial Coordination Center

    collaborator OTHER
  • Yeungnam University Hospital

    lead OTHER

Principal Investigators

  • Hunn Jung Jin, MD · Yeungnam University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-30
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03327363 on ClinicalTrials.gov